Singular Genomics Systems is a medical instruments & supplies business based in the US. Singular Genomics Systems shares (OMIC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $20.01 – the same closing value as a week prior. Singular Genomics Systems employs 255 staff and has a trailing 12-month revenue of around $2.7 million.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – OMIC.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Singular Genomics Systems stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
5 of 5 results
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Singular Genomics Systems stock price (NASDAQ: OMIC)
Use our graph to track the performance of OMIC stocks over time.
Is it a good time to buy Singular Genomics Systems stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Singular Genomics Systems price performance over time
Historical closes compared with the close of $20.01 from 2025-02-21
1 week (2025-09-28)
N/A
1 month (2025-09-05)
N/A
3 months (2025-07-05)
N/A
6 months (2025-04-05)
N/A
1 year (2024-10-09)
32.08%
2 years (2023-10-06)
80.27%
3 years (2022-10-07)
72.9
5 years (2020-10-05)
N/A
Singular Genomics Systems financials
Revenue TTM
$2.7 million
Gross profit TTM
$-1,354,000
Return on assets TTM
-24.21%
Return on equity TTM
-53.57%
Profit margin
0%
Book value
$49.16
Market Capitalization
$50.8 million
TTM: trailing 12 months
Singular Genomics Systems share dividends
We're not expecting Singular Genomics Systems to pay a dividend over the next 12 months.
You may also wish to consider:
Have Singular Genomics Systems's shares ever split?
Singular Genomics Systems's shares were
split on a 1:30 basis on 25 June 2024
. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Singular Genomics Systems shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Singular Genomics Systems shares which in turn could have impacted Singular Genomics Systems's share price.
Singular Genomics Systems share price volatility
Over the last 12 months, Singular Genomics Systems's shares have ranged in value from as little as $12.4 up to $23.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Singular Genomics Systems's is 1.835. This would suggest that Singular Genomics Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Singular Genomics Systems's beta into context you can compare it against those of similar companies.
Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private. .
Frequently asked questions
What percentage of Singular Genomics Systems is owned by insiders or institutions? Currently 14.102% of Singular Genomics Systems shares are held by insiders and 54.809% by institutions.How many people work for Singular Genomics Systems? Latest data suggests 255 work at Singular Genomics Systems.When does the fiscal year end for Singular Genomics Systems? Singular Genomics Systems's fiscal year ends in December.Where is Singular Genomics Systems based? Singular Genomics Systems's address is: 3010 Science Park Road, San Diego, CA, United States, 92121What is Singular Genomics Systems's ISIN number? Singular Genomics Systems's international securities identification number is: US82933R1005What is Singular Genomics Systems's CUSIP number? Singular Genomics Systems's Committee on Uniform Securities Identification Procedures number is: 82933R100
Features and fees to consider before you open an account with this trading platform.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
